Keratinocyte carcinoma prevention with nicotinamide was cost-effective and patient-centered, reducing treatment costs and providing measurable quality-of-life benefit. ja.ma/4v43xjl
An adolescent boy presented with more than 10-year history of skin discoloration and difficulty protruding the tongue. What is your diagnosis? Take the JAMA Dermatology Clinical Challenge: ja.ma/4e1kOn3
No significant difference in melanoma mortality trends was observed between Germany's #SkinCancerScreening program and neighboring countries, suggesting limited population-level impact. ja.ma/3PWjUPE
No significant difference in melanoma mortality trends was observed between Germany's #SkinCancerScreening program and neighboring countries, suggesting limited population-level impact. ja.ma/3QBvakB
Keratinocyte carcinoma prevention with nicotinamide was cost-effective and patient-centered, reducing treatment costs and providing measurable quality-of-life benefit. ja.ma/4e9TYJH
#HidradenitisSuppurativa is associated with increased risks of self-harm and suicide, highlighting the importance of clinician vigilance and multidisciplinary mental health support. ja.ma/4ehM1Rt
No significant difference in melanoma mortality trends was observed between Germany's #SkinCancerScreening program and neighboring countries, suggesting limited population-level impact. ja.ma/43YQbIX
Pediatric patients waited 68% longer for appointments with pediatric dermatologists than with general dermatologists, and >30% of general dermatologists did not accept new pediatric patients. ja.ma/442Y7ZJ
Among adults with refractory #HidradenitisSuppurativa, golimumab led to durable improvement in disease severity; most responders used doses of 200–300 mg every 3–4 weeks. ja.ma/4ehcBKq
Joachim Hübner, PhD, and Alexander Katalinic, MD, discuss recent findings comparing #melanoma mortality rates in Germany from 2009 to 2022 with those in nine neighboring countries without population-wide screening programs.
🎧 Listen to the podcast:
ja.ma/3Qy67Pp
Interview with Joachim Hübner, MD, SJD, and Alexander Katalinic, MD, authors of Population Skin Cancer Screening and Melanoma Mortality Rates. Hosted by Adewole S. Adamson, MD, MPP.
